Beijing Biostar Pharmaceuticals Co., Ltd.

SEHK:2563 Stock Report

Market Cap: HK$10.5b

Beijing Biostar Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2563?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders3,592,9320.985%
Institutions21,827,2615.99%
Employee Share Scheme58,616,43616.1%
General Public58,798,78616.1%
VC/PE Firms58,853,37016.1%
Private Companies162,899,21544.7%

Dilution of Shares: 2563 only recently listed within the past 12 months


Top Shareholders

Top 13 shareholders own 83.87% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.1%
Beijing Biostar Pharmaceuticals Co., Ltd, ESOP
58,616,436HK$1.7b0%no data
11.1%
Baygen QT Inc
40,505,885HK$1.2b0%no data
9.54%
Tibet Xinsheng Deyuan Venture Capital Management Co., Ltd
34,798,296HK$1.0b0%no data
8.07%
SDIC (Shanghai) Venture Capital Management Co., Ltd.
29,426,685HK$850.4m0%4.38%
8.07%
SDIC Venture Capital Management Co., Ltd.
29,426,685HK$850.4m0%31.05%
6.71%
Tibet Renhe Zhengtai Venture Capital Management Co., Ltd.
24,475,926HK$707.4m0%no data
6.71%
Shanghai Haidai Botai Enterprise Management Centre
24,475,926HK$707.4m0%no data
5.99%
Shenzhen Efung Investment Management Limited Partnership Enterprise
21,827,261HK$630.8m0%no data
5.27%
Zhuhai Huajin Haoyuan Enterprise Management Partnership (Limited Partnership)
19,220,863HK$555.5m0%no data
3.84%
Zhuhai Huaxin Haoyuan Business Management Partnership (Limited Partnership)
14,002,034HK$404.7m0%no data
1.37%
Zhuhai Huarong Haoyuan Enterprise Management Partnership (Limited Partnership)
5,000,724HK$144.5m0%no data
0.99%
Li Tang
3,592,932HK$103.8m0%no data
0.12%
Beijing Baygen Technologies Ltd.
419,561HK$12.1m0%no data